See more : Keen Ocean International Holding Limited (8070.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Neptune Wellness Solutions Inc. (NEPT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neptune Wellness Solutions Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- China Shenghai Group Limited (1676.HK) Income Statement Analysis – Financial Results
- Grand City Properties S.A. (GRDDY) Income Statement Analysis – Financial Results
- Tiidal Gaming Group Corp. (TIDL.CN) Income Statement Analysis – Financial Results
- China Art Financial Holdings Limited (1572.HK) Income Statement Analysis – Financial Results
- XMReality AB (publ) (XMMRF) Income Statement Analysis – Financial Results
Neptune Wellness Solutions Inc. (NEPT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neptunewellness.com
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 52.62M | 61.01M | 44.49M | 29.58M | 24.44M | 27.65M | 43.22M | 22.63M | 15.07M | 19.50M | 25.95M | 19.25M | 17.06M | 12.05M | 10.32M | 7.60M | 6.28M | 4.01M | 1.66M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 74.45M | 71.58M | 80.07M | 31.42M | 16.83M | 21.32M | 31.40M | 18.06M | 23.09M | 16.97M | 15.63M | 9.12M | 14.21M | 10.61M | 8.91M | 5.88M | 5.90M | 3.62M | 2.71M | 2.71M | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -21.84M | -10.58M | -35.58M | -1.84M | 7.61M | 6.32M | 11.82M | 4.57M | -8.02M | 2.52M | 10.31M | 10.13M | 2.85M | 1.43M | 1.41M | 1.72M | 382.33K | 398.16K | -1.05M | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | -41.51% | -17.34% | -79.96% | -6.22% | 31.15% | 22.88% | 27.34% | 20.18% | -53.20% | 12.93% | 39.75% | 52.64% | 16.68% | 11.91% | 13.69% | 22.57% | 6.09% | 9.92% | -62.95% | -62.95% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 484.22K | 1.10M | 2.43M | 2.94M | 7.29M | 15.30M | 6.69M | 7.14M | 9.98M | 8.53M | 8.18M | 3.93M | 2.59M | 2.61M | 487.30K | 362.29K | 338.33K | 155.71K | 175.82K | 597.55K | 647.78K | 419.88K | 103.26K | 103.26K |
General & Administrative | 0.00 | 0.00 | 89.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.60M | 26.52M | 15.32M | 9.86M | 736.02K | 461.05K | 2.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 357.74K | 18.06K | 18.06K |
Selling & Marketing | 0.00 | 0.00 | -19.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.45M | 2.24M | 2.41M | 2.10M | 0.00 | 0.00 | 2.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.83K | 11.83K | 0.00 |
SG&A | 46.42M | 75.81M | 81.62M | 62.16M | 15.29M | 15.30M | 15.75M | 13.75M | 23.63M | 32.00M | 18.15M | 11.96M | 736.02K | 461.05K | 4.52M | 2.65M | 2.65M | 0.00 | 0.00 | 1.17M | 1.01M | 369.57K | 18.06K | 18.06K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25M | 730.97K | 1.05M | 599.87K | 532.19K | 944.48K | 777.08K | 707.85K | 33.57K | 23.79K | 5.77K | 0.00 |
Operating Expenses | 46.91M | -92.30M | -122.78M | -53.99M | -30.42M | 2.48M | -6.34M | -15.99M | -20.84M | -24.77M | -29.26M | 15.90M | 4.57M | 3.80M | 5.61M | 3.54M | 1.28M | 932.80K | 883.67K | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
Cost & Expenses | 102.00M | -20.71M | -42.71M | -22.57M | -13.59M | 23.81M | 25.06M | 2.08M | 2.25M | -7.80M | -13.63M | 25.01M | 18.79M | 14.42M | 14.51M | 9.42M | 7.18M | 4.55M | 3.59M | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
Interest Income | 1.45K | 7.12K | 38.33K | 106.63K | 184.73K | 176.14K | 0.00 | 78.47K | 122.76K | 12.82K | 145.69K | 124.58K | 22.88K | 43.27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 30.08K | 0.00 |
Interest Expense | 2.20M | 1.54M | 916.09K | 411.58K | 340.87K | 1.04M | -2.49M | 1.07M | 696.38K | 0.00 | 156.56K | 381.81K | 397.89K | 645.42K | 1.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 0.00 |
Depreciation & Amortization | 3.69M | 7.60M | 23.96M | 7.93M | 3.05M | 3.54M | 3.52M | 2.58M | 1.72M | 352.94K | 613.20K | 768.41K | 943.32K | 730.97K | 599.87K | 532.19K | 966.03K | 797.10K | 724.96K | 39.90K | 23.79K | -5.77K | -5.77K | 0.00 |
EBITDA | -63.05M | -79.89M | -95.65M | -58.94M | -11.84M | -18.99M | -4.88M | -13.19M | -39.51M | -37.27M | -14.86M | -4.87M | -3.41M | -1.59M | -3.34M | -1.11M | -950.60K | 324.37K | -1.20M | -1.76M | -1.66M | -789.45K | -121.32K | -121.32K |
EBITDA Ratio | -119.84% | -130.95% | -214.99% | -199.28% | -48.43% | -68.69% | -11.28% | -58.27% | -262.19% | -191.16% | -57.26% | -25.30% | -20.01% | -13.22% | -32.39% | -14.59% | -15.14% | 8.08% | -72.51% | -106.11% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -66.74M | -87.49M | -119.61M | -66.87M | -14.88M | -22.53M | -8.40M | -15.77M | -41.23M | -37.62M | -15.47M | -5.76M | -1.87M | -3.01M | -4.19M | -1.83M | -900.48K | -534.64K | -1.93M | -1.80M | -1.68M | -795.22K | -121.32K | -121.32K |
Operating Income Ratio | -126.85% | -143.41% | -268.84% | -226.08% | -60.89% | -81.50% | -19.44% | -69.67% | -273.60% | -192.97% | -59.63% | -29.94% | -10.96% | -25.01% | -40.61% | -24.02% | -14.34% | -13.32% | -116.18% | -108.51% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -53.28M | -17.02M | -40.94M | 10.61M | -8.14M | 30.23M | 11.38M | 3.01M | 11.65M | 15.38M | -3.49M | 138.13K | 2.63M | 1.55M | 2.30M | -184.53K | 1.94M | -61.91K | -1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | -120.02M | -105.55M | -160.55M | -56.26M | -23.02M | 7.70M | 2.98M | -12.76M | -29.58M | -22.24M | -18.96M | -5.63M | 760.09K | -1.46M | -1.89M | -2.01M | 115.69K | -596.54K | -1.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -228.11% | -173.01% | -360.85% | -190.22% | -94.19% | 27.85% | 6.91% | -56.37% | -196.27% | -114.06% | -73.08% | -29.22% | 4.46% | -12.12% | -18.31% | -26.45% | 1.84% | -14.86% | -119.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -38.31M | -11.82M | 4.37M | 4.60M | 170.01K | 1.64M | 2.17M | 1.93M | 245.09K | 0.00 | 1.00M | -1.01M | -2.25M | 645.42K | 620.39K | 678.09K | -95.65K | 873.96K | 603.31K | 628.25K | -12.48K | -18.54K | 5.77K | 121.32K |
Net Income | -81.71M | -93.73M | -154.80M | -60.86M | -23.19M | 17.53M | 6.38M | -7.47M | -27.96M | -16.64M | -16.77M | -4.62M | 527.52K | -1.46M | -4.81M | -2.50M | -804.82K | -1.41M | -2.59M | -2.43M | -1.67M | -765.13K | -121.32K | -121.32K |
Net Income Ratio | -155.30% | -153.64% | -347.93% | -205.77% | -94.88% | 63.41% | 14.77% | -33.01% | -185.54% | -85.35% | -64.64% | -24.00% | 3.09% | -12.12% | -46.62% | -32.95% | -12.82% | -35.08% | -156.24% | -146.35% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -138.09 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
EPS Diluted | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -140.00 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
Weighted Avg Shares Out | 295.31K | 120.61K | 86.54K | 64.27K | 56.81K | 56.14K | 55.68K | 53.36K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
Weighted Avg Shares Out (Dil) | 295.31K | 120.61K | 86.63K | 64.27K | 56.81K | 56.69K | 55.82K | 54.10K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
Neptune Announces Receipt of NASDAQ Notification
Top Canadian Cannabis Stocks Under $1 to Watch in July 2023: Affordable Investments with High Growth Potential
Neptune Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results
3 Marijuana Stocks To Keep On Your Radar This Month
Neptune Wellness Solutions Inc. Closes US$4 Million Public Offering
Why Is Neptune Wellness Solutions (NEPT) Stock Down 42% Today?
Neptune Wellness Solutions Inc. Announces Pricing of US$4 Million Public Offering
Neptune Wellness' Organic Baby Food Brand, Sprout Organics, Secures Inventory Financing with Alterna Capital Solutions LLC
Neptune Wellness Announces Agreement on Price of Option to Acquire Remaining Ownership Interest of Organic Baby Food Brand, Sprout Organics
Neptune Wellness Expands Sprout Organics CoComelon Co-Branded Organic Baby Food into Target Stores
Source: https://incomestatements.info
Category: Stock Reports